But I'm confident that, thanks to you, we've framed the history of this, which, by the way, is fascinating and kind of where we are now very, very well
STEP 4 (Rubino et al., JAMA 2021) addressed the maintenance question: after 20 weeks of semaglutide run-in (during which participants lost a mean of 10.6% of body weight), those randomized to continue semaglutide for 48 more weeks lost an additional 7.9%, while those switched to placebo regained 6.9%
For patients, the vote may eventually affect how certain individualized prescriptions can be prepared by traditional compounding pharmacies
What if my pharmacy gives me a different concentration than last time
The decision belongs to your prescriber